SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Royce Biomedical (RYBO-BB) - any thoughts?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rob who wrote (33)7/23/1998 11:58:00 AM
From: Neil_98  Read Replies (2) of 42
 

Rob,

Good questions and thanks for ignoring rainbow trout.

The basic difference in technology between Royce and Response (from what I can tell) is that Royce's product line is self diagnostic. Basically the kits can be administered at home or at a clinic by anyone, not necessarily a medical person. Royce's kits are not designed for repeat use and will wholesale for several dollars, instead of a thousand dollars.

Royce is in the finishing stages of a complete restructuring. Management has been changed, facilities are being moved, and the stock has been rolled back 5 for 1. There are currently less than 2 million shares out. Additionally, the corporate communications department has been changed and we are just starting a comprehensive marketing program.

The last few weeks have been positive. The stock has moved from about $.25US up to about $0.45US yesterday. We are certainly optimistic about the continuing progress that we have experienced since initiating this restructuring.

Our web site has more detailed information on the product side.

1-800-661-7844
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext